ANUSOL HC

Valsts: Īrija

Valoda: angļu

Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)

Nopērc to tagad

Lejuplādēt Produkta apraksts (SPC)
15-08-2017

Aktīvā sastāvdaļa:

HYDROCORTISONE ACETATE ; BENZYL BENZOATE ; BISMUTH OXIDE ; BALSAM PERU ; ZINC OXIDE ; BISMUTH SUBGALLATE

Pieejams no:

Church & Dwight UK Limited

ATĶ kods:

C05AA01

SNN (starptautisko nepatentēto nosaukumu):

HYDROCORTISONE ACETATE ; BENZYL BENZOATE ; BISMUTH OXIDE ; BALSAM PERU ; ZINC OXIDE ; BISMUTH SUBGALLATE

Deva:

%w/w

Zāļu forma:

Suppositories

Receptes veids:

Product not subject to medical prescription

Ārstniecības joma:

hydrocortisone

Autorizācija statuss:

Marketed

Autorizācija datums:

1990-03-30

Produkta apraksts

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Anusol HC Suppositories
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 2.8g suppository contains:
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Suppository
Off white suppositories.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Anusol HC Suppositories are indicated for the symptomatic relief of
external and internal haemorrhoids, proctitis,
cryptitis, anal fissures, pruritus ani and perianal sinuses. Also
indicated post-operatively in ano-rectal surgical
procedures.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Intrarectal.
ADULTS:
Remove wrapper and insert one suppository into the anus at night, in
the morning and after each evacuation, up to a
maximum of three a day.
Not to be taken orally.
ELDERLY (OVER 65 YEARS):
As for adults.
CHILDREN:
Not recommended.
4.3 CONTRAINDICATIONS
Hypersensitivity to the active substance(s) or to any of the
excipients listed in section 6.1
Hydrocortisone Acetate
10 mg
Benzyl Benzoate
33 mg
Bismuth oxide
24 mg
Balsam Peru
49 mg
Zinc Oxide
296 mg
Bismuth Subgallate
59 mg
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_3_
_1_
_/_
_0_
_7_
_/_
_2_
_0_
_1_
_7_
_C_
_R_
_N_
_ _
_2_
_1_
_9_
_0_
_5_
_9_
_7_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
Tubercular, fungal, bacterial and viral lesions including herpes
simplex, vaccinia and varicella.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Patients with rectal bleeding or blood in the stool should talk to
                                
                                Izlasiet visu dokumentu
                                
                            

Skatīt dokumentu vēsturi